Advertisement
Research Article| Volume 379, P18-21, August 15, 2017

Download started.

Ok

Long term follow-up on quality of life and its relationship to motor and cognitive functions in Parkinson's disease after deep brain stimulation

      Highlights

      • Long-term improvements in HRQOL were not maintained after STN-DBS in PD patients.
      • Improvement in motor functions was not correlated with HRQOL after STN-DBS.
      • Cognitive functions were relatively preserved after STN-DBS for five years.

      Abstract

      Introduction

      We aimed to examine temporal changes in health-related quality of life (HRQOL) and its relationship with motor and cognitive functions in patients with Parkinson's disease (PD) after subthalamic nucleus deep brain stimulation (STN-DBS).

      Methods

      In total, 31 patients with PD were enrolled in this study (mean age: 66.7 ± 0.9 years; mean disease duration: 11.6 ± 3.7 years). Participants completed the Unified Parkinson's Disease Rating Scale and the Parkinson's Disease Questionnaire-39. Cognitive function was assessed using the Mini Mental State Examination, the Frontal Assessment Battery, and the Montreal Cognitive Assessment. Postoperative evaluation was performed at three months, one year, three years, and five years after surgery; temporal changes in the correlation between HRQOL and motor and cognitive functions were evaluated at all follow-up periods.

      Results

      All patients completed postoperative clinical evaluations after three months, after one year. Of the 31 participants, twelve completed postoperative clinical evaluations after three years and seven after five years. Motor functions showed significant improvement over the five-year follow-up period. The mobility subdomain of the HRQOL worsened whereas the total score did not change significantly over years. Cognitive functions were not significantly impaired during follow-up periods. HRQOL was basically not significantly correlated with motor and cognitive functions during the follow-up period.

      Conclusions

      The mobility subdomain of the HRQOL worsened after surgery, and the improvement in motor functions was basically not correlated with HRQOL after STN-DBS in patients with PD. Cognitive functions were not significantly impaired during follow-up periods.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Okun M.S.
        Deep-brain stimulation for Parkinson's disease.
        N. Engl. J. Med. 2012; 367: 1529-1538https://doi.org/10.1056/NEJMct1208070
        • Krack P.
        • Batir A.
        • Van Blercom N.
        • Chabardes S.
        • Fraix V.
        • Ardouin C.
        • Koudsie A.
        • Limousin P.D.
        • Benazzouz A.
        • LeBas J.F.
        • Benabid A.L.
        • Pollak P.
        Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease.
        N. Engl. J. Med. 2003; 349: 1925-1934
        • Castrioto A.
        • Lozano A.M.
        • Poon Y.Y.
        • Lang A.E.
        • Fallis M.
        • Moro E.
        Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation.
        Arch. Neurol. 2011; 68: 1550-1556https://doi.org/10.1001/archneurol.2011.182
        • Schuepbach W.M.
        • Rau J.
        • Knudsen K.
        • Volkmann J.
        • Krack P.
        • Timmermann L.
        • Hälbig T.D.
        • Hesekamp H.
        • Navarro S.M.
        • Meier N.
        • Falk D.
        • Mehdorn M.
        • Paschen S.
        • Maarouf M.
        • Barbe M.T.
        • Fink G.R.
        • Kupsch A.
        • Gruber D.
        • Schneider G.H.
        • Seigneuret E.
        • Kistner A.
        • Chaynes P.
        • Ory-Magne F.
        • Brefel Courbon C.
        • Vesper J.
        • Schnitzler A.
        • Wojtecki L.
        • Houeto J.L.
        • Bataille B.
        • Maltête D.
        • Damier P.
        • Raoul S.
        • Sixel-Doering F.
        • Hellwig D.
        • Gharabaghi A.
        • Krüger R.
        • Pinsker M.O.
        • Amtage F.
        • Régis J.M.
        • Witjas T.
        • Thobois S.
        • Mertens P.
        • Kloss M.
        • Hartmann A.
        • Oertel W.H.
        • Post B.
        • Speelman H.
        • Agid Y.
        • Schade-Brittinger C.
        • Deuschl G.
        • EARLYSTIM Study Group
        Neurostimulation for Parkinson's disease with early motor complications.
        N. Engl. J. Med. 2013; 368: 610-622https://doi.org/10.1056/NEJMoa1205158
        • Siderowf A.
        • Jaggi J.L.
        • Xie S.X.
        • Loveland-Jones C.
        • Leng L.
        • Hurtig H.
        • Colcher A.
        • Stern M.
        • Chou K.L.
        • Liang G.
        • Maccarone H.
        • Simuni T.
        • Baltuch G.
        Long-term effects of bilateral subthalamic nucleus stimulation on health-related quality of life in advanced Parkinson's disease.
        Mov. Disord. 2006; 21: 746-753
        • Gibb W.R.
        • Lees A.J.
        The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.
        J. Neurol. Neurosurg. Psychiatry. 1988; 51: 745-752
        • Tomlinson C.L.
        • Stowe R.
        • Patel S.
        • Rick C.
        • Gray R.
        • Clarke C.E.
        Systematic review of levodopa dose equivalency reporting in Parkinson's disease.
        Mov. Disord. 2010; 25: 2649-2653https://doi.org/10.1002/mds.23429
        • Floden D.
        • Cooper S.E.
        • Griffith S.D.
        • Machado A.G.
        Predicting quality of life outcomes after subthalamic nucleus deep brain stimulation.
        Neurology. 2014; 83: 1627-1633https://doi.org/10.1212/WNL
        • Sobstyl M.
        • Ząbek M.
        • Górecki W.
        • Mossakowski Z.
        Quality of life in advanced Parkinson's disease after bilateral subthalamic stimulation: 2 years follow-up study.
        Clin. Neurol. Neurosurg. 2014; 124: 161-165https://doi.org/10.1016/j.clineuro
        • Tykocki T.
        • Szalecki K.
        • Koziara H.
        • Nauman P.
        • Mandat T.
        Quality of life and depressive symptoms in Parkinson's disease after subthalamic deep brain stimulation: a 2-year follow-up study.
        Turk. Neurosurg. 2013; 23: 379-384https://doi.org/10.5137/1019-5149.JTN.7184-12.1
        • Lezcano E.
        • Gómez-Esteban J.C.
        • Tijero B.
        • Bilbao G.
        • Lambarri I.
        • Rodriguez O.
        • Villoria R.
        • Dolado A.
        • Berganzo K.
        • Molano A.
        • de Gopegui E.R.
        • Pomposo I.
        • Gabilondo I.
        • Zarranz J.J.
        Long-term impact on quality of life of subthalamic nucleus stimulation in Parkinson's disease.
        J. Neurol. 2016; 263: 895-905https://doi.org/10.1007/s00415-016-8077-4
        • Martinez-Fernandez R.
        • Pelissier P.
        • Quesada J.L.
        • Klinger H.
        • Lhommée E.
        • Schmitt E.
        • Fraix V.
        • Chabardes S.
        • Mertens P.
        • Castrioto A.
        • Kistner A.
        • Broussolle E.
        • Pollak P.
        • Thobois S.
        • Krack P.
        Postoperative apathy can neutralise benefits in quality of life after subthalamic stimulation for Parkinson's disease.
        J. Neurol. Neurosurg. Psychiatry. 2016; 87: 311-318https://doi.org/10.1136/jnnp-2014-310189
        • Basiago A.
        • Binder D.K.
        Effects of deep brain stimulation on autonomic function.
        Brain Sci. 2016; 6 (pii: E33)